Comparison of titanium-nitride-oxidecoated stents with zotarolimus-eluting stents for coronary revascularization: A randomized controlled trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 6, 2011, Pages 672-682

  Pilgrim, Thomas ^a   Rber, Lorenz ^a   Limacher, Andreas ^a   Löffel, Lukas ^a   Wenaweser, Peter ^a   Cook, Stéphane ^d   Stauffer, Jean Christophe ^d   Togni, Mario ^a   Vogel, Rolf ^a   Garachemani, Ali ^c   Moschovitis, Aris ^a   Khattab, Ahmed A ^a   Seiler, Christian ^a   Meier, Bernhard ^a   Jüni, Peter ^a,b   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Sonnenhof Clinic   (Switzerland)

^d UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

passive stent coating; titanium nitride oxidecoated stent(s); zotarolimus eluting stent(s)

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; ENDEAVOR; NITROGEN OXIDE; TITANIUM; TITANIUM NITRIDE OXIDE; TROPONIN; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; AGED; ARTICLE; BARE METAL STENT; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SIROLIMUS; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; SWITZERLAND; TICLOPIDINE; TITANIUM;

EID: 79959497515     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.02.017     Document Type: Article

References (26)

1. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
2. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
3. P.W. Serruys, M.J. Kutryk, and A.T. Ong Coronary-artery stents N Engl J Med 354 2006 483 495 (Pubitemid 43200299)
4. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
5. P. Wenaweser, J. Daemen, and M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
6. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularization (LEADERS): a randomized non-inferiority trial Lancet 372 2008 1163 1173
7. M.B. Leon, L. Mauri, J.J. Popma ENDEAVOR IV Investigators A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-months outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554
8. G.W. Stone, A. Rizvi, W. Newman SPIRIT IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
9. S. Windecker, R. Simon, and M. Lins Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial Circulation 111 2005 2617 2622 (Pubitemid 40740861)
10. I.T. Meredith, J. Ormiston, and R. Whitbourn First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I trial EuroIntervention 1 2005 157 164
11. J. Fajadet, W. Wijns, G.J. Laarman ENDEAVOR II Investigators Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment for native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
12. D.W. Park, Y.H. Kim, and S.C. Yun Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent With Sirolimus-Eluting and Paclitaxel-Eluting Stent for Coronary Lesions) randomized trial J Am Coll Cardiol 56 2010 1187 1195
13. M.B. Leon, E. Nikolsky, D.E. Cutlip ENDEAVOR IV Investigators Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial J Am Coll Cardiol Intv 3 2010 1043 1050
14. S. Windecker, I. Mayer, G. De Pasquale Working Group on Novel Surface Coating of Biomedical Devices (SCOL) Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia Circulation 104 2001 928 933 (Pubitemid 32778045)
15. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
16. K.F. Schulz, D.G. Altman, D. Moher CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 2010 726 732
17. R. Komatsu, M. Ueda, T. Naruko, A. Kojima, and A.E. Becker Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immune-histochemical analyses Circulation 98 1998 224 233 (Pubitemid 28337613)
18. J.M. Garasic, E.R. Edelman, J.C. Squire, P. Seifert, M.S. Williams, and C. Rogers Stent and artery geometry determine intimal thickening independent of arterial injury Circulation 101 2000 812 818 (Pubitemid 30100090)
19. A. Kastrati, J. Mehili, and J. Dirschinger Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 2001 2816 2821 (Pubitemid 32550070)
20. L. Martinez-Elbal, J.M. Ruiz-Nodar, and J. Zueco Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study The DISCO trial. Direct Stenting of Coronary Arteries Eur Heart J 23 2002 633 640 (Pubitemid 35204248)
21. M.-C. Morice, P.W. Serruys, J.E. Sousa RAVEL Study Group A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780 (Pubitemid 34586912)
22. M.B. Leon, P.S. Teirstein, and J.W. Mosis Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N Engl J Med 344 2001 250 256 (Pubitemid 32108529)
23. H.P. Schultheiss, E. Grube, and K.H. Kuck Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry EuroIntervention 3 2007 76 81
24. D.E. Kandzari, M.B. Leon, J.J. Popma ENDEAVOR III Investigators Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial J Am Coll Cardiol 48 2006 2440 2447 (Pubitemid 44881222)
25. J.B. Hermiller, A. Raizner, L. Cannon TAXUS-IV Investigators Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial J Am Coll Cardiol 45 2005 1172 1179 (Pubitemid 40523133)
26. K.W. Park, C.H. Kim, and H.Y. Lee Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents Am Heart J 159 2010 44653.e3